Develops drugs for obesity and inflammatory diseases.
Jun 2026Revenue $8.83M/yrExpenses $17.5M/yr
Fell below break-even May 2020Cash runway ≈ 7 months from Jun 2026
Figures by year
When will Palatin Technologies be profitable again?
Its expenses passed its revenue in May 2020. In the 12 months to Jun 2026, revenue was $8.83M and expenses $17.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2026 | $8.83M | $17.5M | −$8.67M |
| Jun 2025 | $0.00 | $17.5M | −$17.5M |
| Jun 2024 | $4.49M | $27.0M | −$22.5M |
| Jun 2023 | $4.85M | $37.3M | −$32.5M |
| Jun 2022 | $1.47M | $38.1M | −$36.6M |
| Jun 2021 | −$189K | $33.2M | −$33.4M |
| Jun 2020 | $118K | $23.7M | −$23.6M |
| Jun 2019 | $60.3M | $24.6M | $35.7M |
| Jun 2018 | $67.1M | $41.2M | $25.9M |
| Jun 2017 | $67.1M | $41.2M | $25.9M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.